Fundai

Exir Pharmaceutical Company (DELER) income statement

Operating revenue through to net profit and earnings per share

Ticker
DELER
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Operating revenue83,344,58328,373,34323,201,17619,904,65811,853,14911,649,272
Cost of operating revenue-33,006,844-15,462,364-13,884,857-10,495,626-6,267,993-5,096,967
Gross profit (loss)50,337,73912,910,9799,316,3199,409,0325,585,1566,552,305
Selling, general and administrative expenses-2,116,452-833,892-626,426-374,401-526,967-392,745
Other income39,12311,24431,3937,03723,4816,487
Other expenses-346,707-98,480-26,681-43,795-21,249-30,543
Operating profit (loss)47,913,70311,989,8518,694,6058,997,8735,060,4216,135,504
Finance costs-3,741,647-2,386,179-2,230,346-1,668,954-752,970-370,051
Other non-operating income and expenses273,300184,161494,273312,241196,86031,626
Profit (loss) from continuing operations before tax44,445,3569,787,8336,958,5327,641,1604,504,3115,797,079
Current year tax-10,293,477-2,168,297-1,462,234-1,677,681-967,037-1,243,936
Net profit (loss) from continuing operations34,151,8797,522,9195,450,5515,963,4793,537,2744,553,143
Net profit (loss)34,151,8797,522,9195,450,5515,963,4793,537,2744,553,143
Basic earnings (loss) per share3,709 rials816 rials2,425 rials2,644 rials3,145 rials4,047 rials
Net earnings (loss) per share, rials3,706 rials817 rials2,423 rials2,651 rials1,573 rials4,048 rials
Capital9,217,0009,217,0002,250,0002,250,0002,250,0001,125,000

Reporting periods

90 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.